Brandywine Global Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-121,400
Closed -$2.95M – 672
2024
Q3
$2.95M Sell
121,400
-51,600
-30% -$996K 0.02% 485
2024
Q2
$2.9M Sell
173,000
-114,700
-40% -$1.84M 0.02% 505
2024
Q1
$3.72M Hold
287,700
– – 0.03% 461
2023
Q4
$3.33M Buy
287,700
+30,500
+12% +$344K 0.03% 469
2023
Q3
$3.28M Buy
257,200
+44,900
+21% +$637K 0.03% 459
2023
Q2
$2.91M Buy
+212,300
New +$3.04M 0.02% 488

Other funds holding PAHC

Brandywine Global Investment Management's PAHC Position: Q4 2024 in Review

Brandywine Global Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 121,400 shares — an estimated $2.95M sold.

Brandywine Global Investment Management first reported a position in PAHC in Q2 2023 and held it in 6 quarters. The position peaked at $3.72M in Q1 2024. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Brandywine Global Investment Management reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 121,400 Phibro Animal Health shares in Q4 2024, an estimated $2.95M.
  • Brandywine Global Investment Management first reported a position in Phibro Animal Health in Q2 2023 and held it in 6 quarters.
  • Brandywine Global Investment Management's Phibro Animal Health position peaked at $3.72M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Brandywine Global Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.